← FDA DRUG APPROVALS

FDA ANDA · ANDA085628

SULFISOXAZOLE

Sponsor: RISING

APPLICATION
ANDA085628
TYPE
ANDA
ORIGINAL APPROVAL
1977-06-13
LATEST ACTION
2001-05-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

SULFISOXAZOLEDiscontinued
SULFISOXAZOLE 500MG · TABLET · ORAL

Approval history

2001-05-09Manufacturing (CMC) · Supplement 61AP
2000-01-21Manufacturing (CMC) · Supplement 60AP
1995-08-04Manufacturing (CMC) · Supplement 59AP
1984-12-31Manufacturing (CMC) · Supplement 56AP
1984-12-31Manufacturing (CMC) · Supplement 54AP
1984-12-31Manufacturing (CMC) · Supplement 55AP
1983-08-22Manufacturing (CMC) · Supplement 53AP
1982-07-23Manufacturing (CMC) · Supplement 52AP
1982-07-23Manufacturing (CMC) · Supplement 50AP
1982-07-23Manufacturing (CMC) · Supplement 51AP
1982-04-20Manufacturing (CMC) · Supplement 28AP
1982-04-20Manufacturing (CMC) · Supplement 42AP
1982-04-20Manufacturing (CMC) · Supplement 40AP
1982-04-20Manufacturing (CMC) · Supplement 30AP
1982-04-20Manufacturing (CMC) · Supplement 49AP
1982-04-20Manufacturing (CMC) · Supplement 29AP
1982-04-20Manufacturing (CMC) · Supplement 41AP
1977-06-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →